University Of Istinye, Faculty Of Medicine, TURKEY
Prof. Dr. Engin Ulukaya (MD, PhD), graduated from Cerrahpasa Medical Faculty of Istanbul University (Turkey) in 1988, became a clinical biochemist in 1995 and then gained a PhD degree in Biochemistry and Molecular Biology from University of Leeds (the UK) in 2000. He is currently a professor and working at Medical School of University of Uludag. His main research area is the relationship between cancer and cell death/apoptosis. He is especially keen on monitoring the response to chemotherapy and designing more efficient treatments for better management of cancer patients. Among his achievements is the prediction of the response to chemotherapy in cancer patients by translating basic knowledge of apoptosis into medical oncology. He is also interested in the tumor chemosensitivity assay, also called individualized tumor response test, in various solid tumor types. He is currently interested in anticancer drug development against cancer stem cells and has some patents for palladium-based anticancer compounds. He is the president of association for molecular cancer research (MOKAD) in Turkey. He is also a council member of EACR (European Association for Cancer Research) as well as full member of PathoBiology group of EORTC. He was awarded as the most promising laboratory physician of the year at one of the WASPALM congresses held in South Korea in 2003. He has also 30 awards for poster and oral presentations etc with 110 publications in peer-reviewed international journals with 2390 citations (May 2017, By Google Scholar).